Activities per year
Activities
- 1 - 50 out of 194 results
Search results
-
Impact of progestagen alone or associated with estrogen on the coagulation: A state of the art in 2023
Douxfils, J. (Speaker)
1 Dec 2023Activity: Talk or presentation types › Invited talk
-
Innovative applications of global assays in hemostatis
Douxfils, J. (Jury Member)
15 Dec 2023Activity: Examinations › External Thesis
-
Prediction of venous thromboembolism risk associated with combined oral contraceptives: an exploratory model
Morimont, L. (Speaker) & Douxfils, J. (Speaker)
30 Nov 2023Activity: Talk or presentation types › Oral presentation
-
Hemostasis parameters with estetrol/drospirenone - why APC resistance matters
Douxfils, J. (Speaker)
30 Nov 2023Activity: Talk or presentation types › Invited talk
-
Combined Hormonal Contraceptives - Induced Coagulopathies Evaluation of the Prothrombotic State Using a Global Coagulation Assay
Douxfils, J. (Speaker) & Morimont, L. (Speaker)
4 Oct 2023Activity: Talk or presentation types › Invited talk
-
Navigating new regulations in biobanking for clinical studies and research projects
Douxfils, J. (Speaker)
4 Oct 2023Activity: Talk or presentation types › Oral presentation
-
FIGO - XXIVe World Congress of Gynecology and Obstetrics
Douxfils, J. (Speaker)
9 Oct 2023 → 13 Oct 2023Activity: Participating in or organising an event types › Participation in conference
-
Donesta Partner Meeting : Acquired APC resistance as a marker for VTE, how does the estrogens differ?
Douxfils, J. (Keynote speaker)
4 Sept 2023 → 8 Sept 2023Activity: Talk or presentation types › Invited talk
-
Safety profile of E4: Recent advance and evidence
Douxfils, J. (Keynote speaker)
18 Sept 2023Activity: Talk or presentation types › Invited talk
-
Aquired APC-resistance as a marker for VTE, how reliable?
Douxfils, J. (Invited speaker)
27 Aug 2023Activity: Talk or presentation types › Invited talk
-
Évaluation du risque vasculaire des contraceptifs
Douxfils, J. (Invited speaker)
21 Jun 2023 → 23 Jun 2023Activity: Talk or presentation types › Invited talk
-
Risque induit par les oestrogènes de synthèse en clinique
Douxfils, J. (Invited speaker)
8 Jun 2023Activity: Talk or presentation types › Invited talk
-
Fantastic 4 - E4stetrol in Women's Health
Douxfils, J. (Invited speaker) & Foidart, J.-M. (Invited speaker)
4 May 2023 → 6 May 2023Activity: Talk or presentation types › Oral presentation
-
APC resistance as a marker of the risk of VTE in users of oral contraceptives. Practical usefulness for industry and for clinicians
Douxfils, J. (Invited speaker)
26 May 2023Activity: Talk or presentation types › Invited talk
-
Acquired APC resistance as a marker for VTE, how does the estrogens differ?
Douxfils, J. (Invited speaker)
24 Mar 2023Activity: Talk or presentation types › Oral presentation
-
Estétrol: une nouvelle ère dans la contraception
Douxfils, J. (Invited speaker)
11 Feb 2023Activity: Talk or presentation types › Invited talk
-
Thromboembolie veineuse et contraception orale: Quelle stratégie pour minimiser le risque?
Douxfils, J. (Invited speaker) & Morimont, L. (Speaker)
12 Jan 2023Activity: Talk or presentation types › Invited talk
-
Drug monitoring of direct oral anticoagulants: Key considerations and prespectives
Douxfils, J. (Speaker)
3 Nov 2022Activity: Talk or presentation types › Invited talk
-
Hormonal contraception and the risk of venous thrombosis – facts and myths
Douxfils, J. (Speaker)
18 Nov 2022Activity: Talk or presentation types › Invited talk
-
Global coagulation assays in the future of laboratory diagnostics of hemostasis and thrombosis - Interplay between platelets and coagulation
Douxfils, J. (Keynote speaker)
24 Nov 2022Activity: Talk or presentation types › Invited talk
-
Acquired APC resistance as a marker for VTE, how reliable?
Douxfils, J. (Speaker)
7 Oct 2022Activity: Talk or presentation types › Invited talk
-
Low Thrombin Generation in Menopausal Women Using Estetrol (E4)
Morimont, L. (Speaker) & Douxfils, J. (Speaker)
26 Oct 2022Activity: Talk or presentation types › Oral presentation
-
Beeak-out Medical: Hemostasis and update on the Post Authorization Safety Study
Douxfils, J. (Speaker) & Chatel, G. (Speaker)
13 Sept 2022Activity: Talk or presentation types › Invited talk
-
Method validation for haemostasis assays: Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women. An unmet clinical and regulatory need
Douxfils, J. (Speaker)
15 Sept 2022Activity: Talk or presentation types › Invited talk
-
Impact of E4 on hemostasis — Key messages to understand its unique safety profile
Douxfils, J. (Speaker)
13 Sept 2022Activity: Talk or presentation types › Invited talk
-
Linking platelet lipid metabolism and thrombosis: Role of acetyl-CoA carboxylase
Douxfils, J. (Jury Member)
25 Aug 2022Activity: Examinations › External Thesis
-
ISTH 2022 Congress
Morimont, L. (Participant), Didembourg, M. (Participant) & Douxfils, J. (Participant)
9 Jul 2022 → 13 Jul 2022Activity: Participating in or organising an event types › Participation in conference
-
ISTH 2022 Congress
Douxfils, J. (Contributor)
9 Jul 2022 → 13 Jul 2022Activity: Participating in or organising an event types › Participation in conference
-
Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity
Douxfils, J. (Speaker)
4 Jul 2022Activity: Talk or presentation types › Invited talk
-
L’associazione Estetrolo/Drospirenone: approfondimento sui parametri ematocoagulativi | Why APC resistance matters?
Douxfils, J. (Speaker)
14 Jun 2022Activity: Talk or presentation types › Invited talk
-
Impact des traitements hormonaux sur l’hémostase et exploration biologique : développement et perspectives actuelles
Douxfils, J. (Speaker)
7 Jun 2022Activity: Talk or presentation types › Invited talk
-
Monitoring des anticoagulants: Artéfacts ou avantages - Anticoagulants directs oraux
Douxfils, J. (Speaker)
20 Jun 2022Activity: Talk or presentation types › Invited talk
-
11ème symposium annuel du NTHC(Namur Thrombosis & Hemostasis Center)
Laloy, J. (Participant)
17 May 2022Activity: Participating in or organising an event types › Participation in conference
-
11ème symposium annuel du NTHC(Namur Thrombosis & Hemostasis Center)
Morimont, L. (Contributor), Evrard, J. (Contributor), Siriez, R. (Contributor), Douxfils, J. (Contributor), Didembourg, M. (Participant), GILLOT, C. (Participant), Djokoto, H. (Participant) & Haguet, H. (Participant)
17 May 2022Activity: Participating in or organising an event types › Participation in conference
-
Safety profile of E4: recent clinical evidence
Douxfils, J. (Speaker)
12 May 2022Activity: Talk or presentation types › Invited talk
-
Correlation between activated protein C Resistance and the Relative Risk of Venous Thromboembolism in Women Using Hormonal Therapy
Morimont, L. (Speaker) & Douxfils, J. (Speaker)
11 May 2022 → 14 May 2022Activity: Talk or presentation types › Oral presentation
-
16th ESC congress
Morimont, L. (Participant) & Douxfils, J. (Contributor)
25 May 2022 → 28 May 2022Activity: Participating in or organising an event types › Participation in conference
-
Estetrol (E4): a native estrogen whose effect on the liver does not need to be counterbalanced by progestins
Douxfils, J. (Speaker)
27 May 2022Activity: Talk or presentation types › Oral presentation
-
Impact des traitements hormonaux sur l’hémostase et exploration biologique : développement et perspectives actuelles
Douxfils, J. (Speaker)
17 May 2022Activity: Talk or presentation types › Invited talk
-
In vitro and in vivo models of cardiac ischemia : Past and Future
Laloy, J. (Speaker)
21 Mar 2022Activity: Talk or presentation types › Invited talk
-
10 ans de monitoring des anticoagulants oraux. Où en sommes-nous et où allons-nous?
Douxfils, J. (Speaker)
15 Mar 2022Activity: Talk or presentation types › Invited talk
-
Estétrol/drospirénone, le point de vue de l’hém(ost)ato(sio)logue
Douxfils, J. (Speaker)
26 Jan 2022Activity: Talk or presentation types › Invited talk
-
Measurement of Direct Oral Anticoagulants and Contact Pathway Inhibitors
Douxfils, J. (Invited speaker)
18 Jul 2021Activity: Talk or presentation types › Invited talk
-
Thrombotic risk associated with COVID- 19 pathogenesis and unusual thrombosis associated with thrombocytopenia in the context of COVID-19 vaccination
Douxfils, J. (Invited speaker)
24 Jun 2021Activity: Talk or presentation types › Invited talk
-
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients After Two Doses of BNT162b2
Favresse, J. (Invited speaker) & Douxfils, J. (Invited speaker)
7 Jun 2021Activity: Talk or presentation types › Invited talk
-
Contribution des techniques de coagulation à la compréhension de la physiologie et de la physiopathologie de l’hémostase – Applications cliniques
Douxfils, J. (Jury Member)
4 May 2021Activity: Examinations › External Thesis
-
Estetrol (E4): Impact on hemostasis
Douxfils, J. (Invited speaker)
24 May 2021Activity: Talk or presentation types › Invited talk
-
Neutralizing antibodies in COVID-19: Current knowledge and perspectives
Douxfils, J. (Invited speaker)
16 Mar 2021Activity: Talk or presentation types › Invited talk
-
Utilisation des tests chromogéniques anti-FXa dans le cadre du suivi de l’HNF et des HBPM: principes de base et recommandations
Douxfils, J. (Invited speaker)
9 Feb 2021Activity: Talk or presentation types › Invited talk
-
Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need
Douxfils, J. (Invited speaker) & Morimont, L. (Invited speaker)
4 Feb 2021Activity: Talk or presentation types › Invited talk